Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01235702 · ClinicalTrials.gov registry record · Phase 1

Metro Atlanta Heart Disease Study - II (MAHDS II)

A Phase 1 study, sponsored by Morehouse School of Medicine.

Completed
Registry status
Phase 1
Development phase
210
Enrollment target

NCT01235702: Completed Phase 1 study, sponsored by Morehouse School of Medicine.

NCT01235702 is a Phase 1 study that has completed, run by Morehouse School of Medicine. The registered enrollment target is 210 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (250% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01235702, a Phase 1 study, has completed, sponsored by Morehouse School of Medicine.

COMPLETED
Registry status
Phase 1
Development phase
210 participants
Enrollment target

Study Summary

A 12-week treatment/control trial was implemented to assess the effects of a multi component lifestyle program on improvements in body mass index, weight, perceived stress and blood pressure in African American men and women who were at increased risk for cardiovascular disease. It was hypothesized that treatment group would experience significant improvements when compared to the control group.

Primary Outcome

a 12-week behavior modification program was implemented to assess the effects of nutrition counseling, stress reduction education, and directed physical activity on African Americans at increased risk for cardiovascular disease.

Interventions

  • BEHAVIORAL 12-week lifestyle modification

Trial Details

FieldValue
Enrollment Target 210 participants
Start Date 2002-09
Est. Completion 2003-10
Phase Phase 1
Morehouse School of Medicine

13 total trials

What the finished NCT01235702 record still lists

NCT01235702 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (250% higher).

The record links to 0 conditions, and to 1 intervention - of which 12-week lifestyle modification is the first listed.

NCT01235702 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01235702 about?

NCT01235702 is a clinical study titled "Metro Atlanta Heart Disease Study - II (MAHDS II)". A 12-week treatment/control trial was implemented to assess the effects of a multi component lifestyle program on improvements in body mass index, weight, perceived stress and blood pressure in African American men and women who were at increased risk for cardiovascular disease. It was hypothesized ...

What is the current status of trial NCT01235702?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 210 participants. The study started on 2002-09. Estimated completion is 2003-10.

What interventions are being tested in trial NCT01235702?

The interventions under investigation include: 12-week lifestyle modification (BEHAVIORAL).

Who is sponsoring clinical trial NCT01235702?

This trial is sponsored by Morehouse School of Medicine, which has 13 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01235702's enrollment target sits among peer trials

210 245th of 2000 higher than 1,751 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02665923 · 210 participants

    Gastric Emptying in Neonates and Infants After Formula Feeding

  • NCT03322891 · 210 participants · NA

    Improving Health Literacy in African-American Prostate Cancer Patients

  • NCT03544489 · 210 participants · Phase 2

    Effectiveness of Exercise After an ICD

  • NCT04408430 · 210 participants · NA

    The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01235702, the US trial registry maintained by the National Library of Medicine. NCT01235702 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.